Drugs / Protamine Sulfate

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) PROTAMINE SULFATE 1969-08-13 fda.gov

Trials 5 · a red edge is where a trial was stopped

1968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT06215378 May 2025 → Mar 2027 expected aortic valve stenosis Assistance Publique - Hôpitaux de Paris Recruiting No outcome recorded
Phase 41 trial
Phase 4 NCT05426031 Jun 2022 → Jun 2023 disseminated intravascular coagulation University of Miami Completed No outcome recorded
Phase not applicable3 trials
NCT07477977 Mar → Jun 2026 overdue Sohag University Recruiting No outcome recorded
NCT06254404 Mar → Oct 2024 hyperheparinemia University of Liege Unknown No outcome recorded
NCT03787641 Sep 2018 → Dec 2019 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Unknown No outcome recorded
Also used as a comparator or background therapy in 8 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT00073593 Comparator Aug 2003 → May 2004 cardiac valvular defect, coronary artery intramyocardial course The Medicines Company Completed No outcome recorded
Phase 46 trials
Phase 4 NCT05774691 Comparator Nov 2023 → Jan 2026 aortic valve stenosis St. Antonius Hospital Completed No outcome recorded
Phase 4 NCT04628884 Comparator Nov 2020 → Nov 2021 poisoning Fundación Clínica Shaio Unknown No outcome recorded
Phase 4 NCT03140631 Comparator Mar → Nov 2017 atrial fibrillation University of Michigan Completed No outcome recorded
Phase 4 NCT02974660 Comparator Dec 2016 → Jul 2020 aortic valve stenosis Medical University of Warsaw Completed No outcome recorded
Phase 4 NCT01267487 Comparator Jul 2009 → Mar 2010 SANE-Society of Anesthesiology Completed No outcome recorded
Phase not applicable1 trial
NCT00684450 Comparator Jun 2008 → Jun 2011 hemorrhagic disease Montreal Heart Institute Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 14 sources stand behind the page.

FieldValueCited text
Known as Protamine Sulfate “The second syringe will contain either protamine sulfate (1.0 mg/kg) to reverse the systemic heparin for patients in the treatment group, or normal saline for the control group” NCT00253851
6

Protamine Sulfate will be administered via an infusion pump to administer a 50 mg test doze, then 100 mg after 5 min waiting period.” NCT03787641

NCT07477977

NCT06215378

NCT02974660

NCT03140631

NCT05774691

Known as Novo protamine sulfate ChEMBL registry synonym — accepted as the source's own label CHEMBL1201651
Known as Prosulf ChEMBL registry synonym — accepted as the source's own label CHEMBL1201651
Known as Protamine Protamine reverses the effect of heparin by binding to each heparin molecule” NCT04628884
7

ProtamineNCT07477977

NCT06254404

NCT03787641

NCT00073593

NCT01267487

NCT00684450

NCT05426031

Known as Protamine sulphate ChEMBL registry synonym — accepted as the source's own label CHEMBL1201651
Known as Protamines ChEMBL registry synonym — accepted as the source's own label CHEMBL1201651
Known as Protamini sulfas ChEMBL registry synonym — accepted as the source's own label CHEMBL1201651
Known as Sulfate de protamine ChEMBL registry synonym — accepted as the source's own label CHEMBL1201651
Known as Sulfato de protamina ChEMBL registry synonym — accepted as the source's own label CHEMBL1201651
Modality Protein / enzyme biologic “Protamine sulfate is a highly basic protein” NCT03140631
Route Intravenous “Following cuff inflation, the contents of a second syringe will be administered IV over a 5 minute period” NCT00253851